Approval · Notice of Compliance 10553 · 2009
CODEINE CONTIN: Notice of Compliance 10553
Issued August 27, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10553
- Date
- August 27, 2009
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the Dosage and Administration section of the product monograph
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CODEINE CONTIN | Not yet assigned | — |
Medicinal ingredients
- CODEINE SULFATE 25 MG per TAB
- CODEINE 25 MG per TAB
- CODEINE SULFATE 50 MG per TAB
- CODEINE 50 MG per TAB
- CODEINE SULFATE 75 MG per TAB
- CODEINE 75 MG per TAB
- CODEINE SULFATE 100 MG per TAB
- CODEINE 100 MG per TAB